Transox Inc.

Transox Inc., a service-disabled veteran-owned small business (SDVOSB) based in West Columbia, South Carolina, supplies home oxygen and ventilator equipment and in-home healthcare services to the Department of Veterans Affairs as a prime contractor across five regional VA networks, competing predominantly under SDVOSB set-asides and full-and-open designations.

Transox operates exclusively as a prime contractor delivering home oxygen equipment, tanks, canisters, nasal cannulas, and related expendable medical supplies, along with equipment setup, maintenance, and resupply services to veterans receiving in-home healthcare. The company holds SBA certifications as both a veteran-owned small business and service-disabled veteran-owned small business through April 20, 2028. Recent representative work includes a $19 million single-award SDVOSB indefinite-delivery contract with Veterans Integrated Service Network 7 (VISN 7) awarded August 1, 2024, for home oxygen and ventilator services through July 31, 2031; a $52.8 million SDVOSB indefinite-delivery contract with VISN 9 awarded April 1, 2024, for home oxygen delivery services through March 31, 2027; and a $12.8 million SDVOSB indefinite-delivery contract with VISN 8 awarded April 1, 2024, for Orlando home oxygen delivery through March 31, 2029. Work is performed in-house with no subcontractor involvement; the vendor carries 100 percent of contractor hours on federal services contracts captured in the SCI reporting dataset.

Customer concentration is absolute and geographic: Transox serves five VA regional networks across 204 awards accounting for $289.5 million combined potential value. VISN 7 dominates both volume and dollars (161 awards, $108 million), followed by VISN 9 (4 awards, $78.5 million), VISN 8 (32 awards, $49.8 million), VISN 5 (6 awards, $27.7 million), and VISN 4 (1 award, $25.4 million). The VA is the sole customer—no other federal agencies appear in the award footprint.

Transox operates through 20 parent indefinite-delivery vehicles across the five VISN networks. The top vehicles by task-order count are IDC 36C24723D0025 (32 task orders, $10.4 million), IDC 36C24722D0051 (28 task orders, $2.7 million), IDC 36C24724D0023 (21 task orders, $5.2 million), IDC 36C24722D0048 (16 task orders, $5.5 million), and IDC 36C24822D0074 (10 task orders, $5.9 million). Individual task orders under these vehicles are monthly delivery orders, typically ranging from $30,000 to $280,000 per order. All work is priced firm fixed-price and issued against single-award or multiple-award IDIQ vehicles held by specific VA medical centers or networks.

Activity has accelerated sharply: the vendor moved from 14 awards in 2022 to 77 awards in 2025—a 450 percent increase in volume over three years. Awards in 2026 total 39 through September. Six awards with ultimate completion dates in the next twenty-four months carry combined potential value of $25.4 million and face recompete risk.

SCI-reported invoicing of federal service contracts totaled $48.2 million across FY2022 through FY2025, reflecting rapid scaling: FY2023 ($2.1 million, 12.5 FTEs), FY2024 ($18.3 million, 114 FTEs), FY2025 ($27.8 million, 119 FTEs). Government-paid rates on federal services contracts average around $73 per hour, with rates ranging from a 10th percentile of $56.65/hr to a 90th percentile of $101.17/hr. Across SCI-reportable prime contracts, subcontractors perform zero percent of total contractor hours—Transox self-performs all delivery and fulfillment work.

The vendor's footprint is narrowly specialized: 176 awards fall under NAICS 532283 (Home Health Equipment Rental), 28 under NAICS 621610 (Home Health Care Services). Set-aside posture divides between SDVOSB Competitive, SDVOSB Sole Source, and full-and-open awards; the vendor competes under SDVOSB set-asides on approximately 50 percent of recent prime awards and full-and-open on the remainder. No evidence of teaming relationships, subcontractor partnerships, or presence on government-wide acquisition contracts (GWACs) or other inter-agency vehicles appears in the source data. Transox's market position is dependent almost entirely on recurring VA task orders against its existing IDIQ portfolio; recompete of major IDIQ vehicles (particularly the $19 million VISN 7 and $52.8 million VISN 9 contracts) will represent the primary competitive and revenue-continuity risk.